Astrazeneca (AZN) Current Taxes (2009 - 2026)
Astrazeneca (AZN) posted quarterly Current Taxes of $1.5 billion for Q2 2026, up 2.73% year-over-year from $1.4 billion in Q2 2025, and up 213.01% quarter-over-quarter from -$1.3 billion in Q1 2026.
Astrazeneca (AZN) Current Taxes (2009 - 2026) Analysis & Trends
Astrazeneca's Current Taxes history runs 18 years deep, the most recent figure standing at $1.5 billion for Q2 2026.
- In Q2 2026, Current Taxes rose 2.73% year-over-year to $1.5 billion; the TTM figure through Jun 2026 stood at $1.5 billion (up 2.73% YoY), while the FY2025 annual figure was $1.1 billion, down 22.9% from the prior year.
- Current Taxes for Q2 2026 stood at $1.5 billion, up from -$1.3 billion in the prior quarter.
- The five-year high for Current Taxes was $1.6 billion in Q4 2023, with the low at -$1.7 billion in Q1 2025.
- The 5-year median for Current Taxes is -$1.1 billion (2022), against an average of -$430.2 million.
- The sharpest annual moves came in 2022 and 2025: Current Taxes sank 43.12% in 2022, then jumped 193.7% in 2025.
- Astrazeneca's Current Taxes stood at $896.0 million in 2022, then jumped by 76.79% to $1.6 billion in 2023, then retreated by 11.24% to $1.4 billion in 2024, then declined by 22.9% to $1.1 billion in 2025, then jumped by 35.42% to $1.5 billion in 2026.
- Business Quant data shows AZN's Current Taxes at $1.5 billion in Q2 2026, -$1.3 billion in Q1 2026, and $1.1 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 1.05 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | - |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 4.22 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 2.31 Bn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 1.47 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | - |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 653.00 Mn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | -703.04 Mn |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 1.03 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.47 Bn |
| Mar 31, 2026 | -1.30 Bn |
| Dec 31, 2025 | 1.08 Bn |
| Sep 30, 2025 | -1.27 Bn |
| Jun 30, 2025 | 1.43 Bn |
| Mar 31, 2025 | -1.66 Bn |
| Dec 31, 2024 | 1.41 Bn |
| Sep 30, 2024 | -1.47 Bn |
| Jun 30, 2024 | -1.53 Bn |
| Mar 31, 2024 | -1.63 Bn |
| Dec 31, 2023 | 1.58 Bn |
| Sep 30, 2023 | -1.16 Bn |
| Jun 30, 2023 | -1.20 Bn |
| Mar 31, 2023 | -1.20 Bn |
| Dec 31, 2022 | 896.00 Mn |
| Sep 30, 2022 | -1.09 Bn |
| Jun 30, 2022 | -981.00 Mn |
| Mar 31, 2022 | -1.12 Bn |
| Dec 31, 2021 | 916.00 Mn |
| Sep 30, 2021 | -987.00 Mn |